Emily Boja
PhD
Silver Spring, MD, USA

About
Senior Scientist, Office of Chief Scientist
Office of Health Informatics, FDA
Dr. Boja leads the precisionFDA’s biomedical competitions around omics science, as well as outreach activities in building a community of scientists around the analysis of biological datasets to inform regulatory science and advance precision medicine. Prior to joining OHI, she was a Program Director at the Office of Cancer Clinical Proteomic Research, NCI, NIH, who provided scientific expertise and leadership in managing the Clinical Proteomic Tumor Analysis Consortium program.
scientific
Projects
Craniopharyngioma, Medulloblastoma, HGG, (AT/RT), LGG, Ependymoma, Ganglioglioma, DNET, Schwannoma

Adam Resnick
Children’s Hospital of Philadelphia
Philadelphia, PA, USA
research